Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
213. Estrogen receptor antagonist ICI 182,780 inhibits the anti-inflammatory effect of<br />
glucocorticoids<br />
1,2 Salvatore Cuzzocrea, 3 Bruscoli S., 1 Crisafulli C., 1,2 Mazzon E., 3 Agostini M., 1 Muià C.,<br />
2,4 Esposito E.,<br />
3 Di Virgilio R.,<br />
4 Meli R.,<br />
5 Vegeto E.,<br />
5 Maggi A.,<br />
3 Riccar<strong>di</strong> C.<br />
1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina,<br />
Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy; 3 Department of Cinical and<br />
Experimental Me<strong>di</strong>cine, Pharmacology, University of Perugia, Italy;<br />
4 Department of<br />
Experimental Pharmacology, University of Naples “Federico II”, Naples Italy; 5 Department of<br />
Pharmacological Sciences, University of Milan, Italy<br />
Chemioterapia antibatterica, antivirale e antineoplastica<br />
Poster 214 – 228<br />
214. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and ZD6474 in<br />
bladder cancer cell lines<br />
Mey Valentina, Elisa G., Nannizzi S., Ricciar<strong>di</strong> S., Danesi R., Del Tacca M.<br />
Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine,<br />
University of Pisa<br />
215. Synergistic cytotoxycity, inhibition of AKT and C-KIT phosphorylation, modulation of<br />
gene expression by sorafenib and gemcitabine in human pancreatic cancer cells<br />
Ricciar<strong>di</strong> Simona, Giovannetti E. , Nannizzi S., Mey V., Pasqualetti G., Danesi R., Del Tacca<br />
M.<br />
Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />
Pisa<br />
216. Inhibition of STAT 3 increases doxorubicin sensitivity in a human metastatic breast<br />
cancer cell line<br />
Roberta Molteni, Ravizza R., Garibol<strong>di</strong> M.B., Monti E.<br />
Dept. of Structural and Functional Biology, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> dell’Insubria<br />
103<br />
217. In vitro study of the interaction between gemcitabine and sorafeniv in non small<br />
cell lung cancer (NSCLC) A549 cell line<br />
Pasqualetti Giuseppe, Ricciar<strong>di</strong> S., Nannizzi S., Mey V., Elisa G., Danesi R., Del Tacca M.<br />
Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine - University of<br />
Pisa<br />
218. In vitro and in vivo antineoplastic effects of a novel platinum bioconjugate using a<br />
biocompatible polymeric matrix<br />
Garibol<strong>di</strong> Marzia Bruna, Gabano E. 1 , Sparnacci K. 1 , Laus M. 1 , Osella D. 1 , Ravizza R., Molteni<br />
R., Monti E.<br />
DBSF – Pharmacology Section, University of Insubria, Busto Arsizio (VA). 1 Dipartimento <strong>di</strong><br />
Scienze dell’Ambiente e della Vita, Università del Piemonte Orientale “A. Avogadro”,<br />
Alessandria<br />
219. Toxicological evaluation of mepacrine and interferon alfa-2A on U87-MG and Vero<br />
cell colture<br />
Coppi Andrea, Baggio G., Bruni E. Rossi T.<br />
University of Modena and Reggio Emilia- Italy: Departmentof Biome<strong>di</strong>cal Sciences-<br />
Section of Pharmacology; 287 G. Campi st 41100 Modena Italy<br />
pag_dx.indd 1 30/05/2007 4.39.14